Scarica l'app Stockscreener
422.00
1.21%
5.04
Pre-mercato:
420.96
-1.04
-0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VRTX Giù?
Forum
Previsione
Frazionamento azionario
Vertex Pharmaceuticals Inc Borsa (VRTX) Ultime notizie
Merit Financial Group LLC Raises Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Zhang Financial LLC Boosts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Diversify Wealth Management LLC Raises Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
InTrack Investment Management Inc Has $878,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
J2 Capital Management Inc Invests $270,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
McKesson, Vertex Pharmaceuticals among top healthcare Quant picks before Q4 earnings - MSN
Avanza Fonder AB Takes $11.34 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by First Pacific Financial - MarketBeat
RDA Financial Network Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
3 Unstoppable Stocks to Buy in 2025 - The Motley Fool
Vertex's Pain Drug: Big Pharma's Next Major Success? - MSN
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Empirical Asset Management LLC Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Channel Wealth LLC Invests $716,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
HHS says Vertex is ‘grasping at straws’ with Casgevy fertility suit - PharmaLive
Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30? - sharewise
Thurston Springer Miller Herd & Titak Inc. Purchases 673 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock - MSN
How Is The Market Feeling About Vertex Pharmaceuticals? - Benzinga
Burney Co. Has $15.21 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Assenagon Asset Management S.A. Boosts Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today - Benzinga
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials - Yahoo Finance
40 Under 40: Mnwabisi Mbangata, Vertex Pharmaceuticals - MM+M Online
Vertex Therapeutics: The Pain Comes With The Territory For Suzetrigine (VRTX) - Seeking Alpha
Vertex Pharmaceuticals' SWOT analysis: stock outlook balances innovation and valuation - Investing.com
Vertex Pharmaceuticals' (VRTX) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
JPM25: Vertex CEO says pain is its next multi-billion franchise - FirstWord Pharma
Vertex Pharmaceuticals Incorporated : J.P. Morgan Healthcare Conference Presentation 2025 - Marketscreener.com
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Czech National Bank - MarketBeat
International Assets Investment Management LLC Sells 323,990 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings - Yahoo Finance
Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement - Yahoo Finance
US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment - MSN
Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should Know - Yahoo Finance
Forecasting The Future: 23 Analyst Projections For Vertex Pharmaceuticals - Benzinga
CCM Investment Advisers LLC Sells 7,770 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex out-licenses povetacicept to Zai Lab - The Pharma Letter
Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore - BioSpace
Vertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical Trials - MSN
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $460.00 by Analysts at Wells Fargo & Company - MarketBeat
Vertex Pharmaceuticals Incorporated and Zai Lab Limited Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Marketscreener.com
Pfizer Is ‘Too Low To Sell, Let Dividend Do Its Job': Jim CramerNVIDIA (NASDAQ:NVDA), Pfizer (NYSE:PFE) - Benzinga
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Business Wire
Vertex Pharmaceuticals Earnings Preview: What to Expect - Nasdaq
Vertex Pharmaceuticals Earnings Preview: What To Expect - Barchart
Alpine Immune Sciences Leaders Join Frazier After $4.9B Vertex Acquisition Success - StockTitan
Orna Therapeutics collaborates with Vertex Pharmaceuticals to develop approaches for sickle cell disease - MSN
1.68%
2.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):